Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-48,266
Closed -$5.07M 58
2022
Q2
$5.07M Buy
48,266
+1,059
+2% +$135K 1% 54
2022
Q1
$8.13M Sell
47,207
-348
-0.7% -$52K 1.4% 30
2021
Q4
$7.7M Buy
47,555
+9,589
+25% +$1.54M 1.24% 44
2021
Q3
$5.66M Buy
+37,966
New +$7.89M 0.97% 57

Other funds holding AMED

Bell Asset Management's AMED Position: Q3 2022 in Review

Bell Asset Management sold out of Amedisys (AMED) in Q3 2022, closing a stake of 48,266 shares — an estimated $5.07M sold.

Bell Asset Management first reported a position in AMED in Q3 2021 and held it in 4 quarters. The position peaked at $8.13M in Q1 2022. 286 funds tracked by Wall St. Rank hold AMED as of Q3 2022.

  • Bell Asset Management reported no remaining Amedisys position as of Q3 2022 after selling out during the quarter.
  • Bell Asset Management sold 48,266 Amedisys shares in Q3 2022, an estimated $5.07M.
  • Bell Asset Management first reported a position in Amedisys in Q3 2021 and held it in 4 quarters.
  • Bell Asset Management's Amedisys position peaked at $8.13M in Q1 2022.
  • 286 funds tracked by Wall St. Rank held Amedisys as of Q3 2022.

Based on Bell Asset Management's 13F filing for Q3 2022, filed 10 Nov 2022.